Keratoacanthoma

1. High-Yield Summary

• Definition and Biological Behavior: Keratoacanthoma (KA) is a rapid-growing cutaneous squamoproliferative epithelial neoplasm characterized by a central, compact, keratin-filled crater with distinctive overlapping epidermal lips, predominantly arising on hair-bearing, sun-exposed skin of older adults (6th to 8th decades of life, with a 2:1 male-to-female predominance).
• The Subungual Keratoacanthoma Exception: Subungual keratoacanthoma (SKA) represents a distinct, destructive variant arising from the specialized nail unit (hyponychium or sterile matrix). Due to the unyielding osteofibrous constraints of the nail bed directly abutting the distal phalanx (P3) without an intervening subcutaneous adipose layer, SKA does not reliably undergo spontaneous involution and exerts relentless mechanical pressure osteolysis, producing a pathognomonic crescentic, cup-shaped saucerization of the distal phalanx.
• The Diagnostic Malignancy Dilemma: Clinically and histopathologically, KA shares extensive morphological and cytological overlap with well-differentiated cutaneous squamous cell carcinoma (cSCC); superficial, shave, or punch biopsies are strictly contraindicated as they fail to capture the triphasic architecture (buttressing epidermal lips, central keratin crater, and smooth, bulbous, pushing borders at the base), leading to frequent false-positive diagnoses of invasive cSCC or catastrophic underdiagnosis.
• Definitive Surgical Management and Digit Preservation: Complete surgical excision with 4 to 5 mm margins or Mohs micrographic surgery (MMS) achieves cure rates exceeding 95% with low recurrence rates (2% to 8%). For subungual KA, thorough conservative curettage and saucerization with preservation of the underlying periosteum and digital skeleton achieves durable local control and permits spontaneous distal phalanx cortical re-ossification, avoiding unnecessary digital amputation.
• Syndromic Associations and Pharmacologic Triggers: Multiple or eruptive lesions mandate urgent evaluation for Muir-Torre syndrome (DNA mismatch repair deficiency with visceral adenocarcinoma risk), Ferguson-Smith familial multiple keratoacanthoma (TGFBR1 loss-of-function mutations), or paradoxical MAPK pathway activation induced by targeted BRAF inhibitor monotherapy (such as vemurafenib or dabrafenib in metastatic melanoma).

2. Anatomy

Formulating an accurate diagnostic and surgical strategy for keratoacanthoma requires a detailed understanding of the cutaneous architecture of hair-bearing skin, the specialized microanatomy of the distal digital nail unit, and the critical neurovascular structures adjacent to the operative field.

Integumentary and Follicular Microarchitecture

In hair-bearing cutaneous regions, keratoacanthoma originates from the infundibular or isthmic follicular epithelium of pilosebaceous units. The normal integument comprises three distinct structural layers:

• Epidermis: Stratified squamous keratinizing epithelium composed of five discrete strata: stratum basale (proliferative stem cell reservoir anchored to the basement membrane), stratum spinosum (polyhedral keratinocytes linked by desmosomal junctions), stratum granulosum (keratohyalin granules containing profilaggrin and loricrin), stratum lucidum (present in glabrous skin), and stratum corneum (densely packed anucleated corneocytes providing the physical barrier).
• Dermo-Epidermal Junction and Basement Membrane Zone: A complex 100-nm specialized extracellular matrix zone consisting of hemidesmosomes, the lamina lucida (rich in laminin-332), lamina densa (type IV collagen and perlecan), and the sublamina densa fibroreticular zone (type VII collagen anchoring fibrils inserting into papillary dermal collagen bundles). In classic keratoacanthoma, down-growing squamoproliferative lobules maintain an intact or gently displaced basement membrane with smooth, rounded, pushing bulbous margins, in stark contrast to the ragged, permeative single-cell stromal infiltration characteristic of invasive cutaneous squamous cell carcinoma.
• Dermis: Divided into the superficial papillary dermis (loose type I and III collagen fibers, elastin, and rich subpapillary vascular plexuses) and the deep reticular dermis (coarse, thick, interlacing collagen bundles). As keratoacanthoma expands, it displaces the reticular dermis downward, provoking an intense host stromal inflammatory reaction composed of CD4+ and CD8+ T lymphocytes, histiocytes, and plasma cells along its advancing deep frontier.

The Digital Nail Unit and Subungual Compartment

In the musculoskeletal system and hand surgery, keratoacanthoma presents most critically as the subungual keratoacanthoma (SKA) variant. The digital tip contains specialized glabrous skin devoid of pilosebaceous units; SKA arises directly from the squamous epithelium of the nail bed, most frequently originating at the hyponychium or the distal sterile matrix. The perionychium encompasses five distinct anatomic zones:

• Proximal Nail Fold and Eponychium: A double-layered fold of specialized dorsal skin. The dorsal roof transitions into normal digital skin; the ventral floor covers the newly forming nail plate. The cuticle (eponychium) forms a cornified seal that protects the underlying subungual space and germinal matrix from microbial ingress.
• Germinal Matrix: Situated beneath the proximal nail fold and extending distally to the white, convex margin of the lunula. The germinal matrix is the primary proliferative engine of the nail unit, responsible for generating approximately 80% to 90% of total nail plate volume through specialized onychocyte maturation and dense longitudinal keratinization. Surgical disruption or laceration of this structure induces irreversible nail splitting, longitudinal ridging, or permanent onychodystrophy.
• Sterile Matrix: Extends from the distal margin of the lunula to the hyponychium. Composed of a thin, stratified squamous epithelium firmly attached to the undersurface of the nail plate, the sterile matrix contributes the remaining 10% to 20% of ventral nail plate thickness and mediates the frictionless distal translation and longitudinal glide of the growing nail.
• Hyponychium: The epithelial transition zone bridging the distal sterile matrix and the apical digital pulp skin. Characterized by dense, specialized orthokeratinization, the hyponychium establishes the distal mechanical seal protecting the subungual space.
• Lateral Nail Folds (Paronychium): Lateral cutaneous borders that surround and stabilize the lateral edges of the nail plate within the lateral perionychial sulci.

The Subungual Osteofibrous Space and Relationship to the Distal Phalanx

The anatomic relationship between the nail bed and the distal phalanx (P3) is unique within the human body. Unlike hairy skin and subcutaneous tissue elsewhere, the subungual compartment contains no intervening subcutaneous adipose layer (hypodermis). The dermis of the sterile and germinal matrix inserts directly into the periosteum of the distal phalanx via dense collagenous anchoring fibers (Sharpey-like fibers).

Bound dorsally by the rigid, non-compliant keratinized nail plate, laterally by the collateral ligaments and paronychial folds, and deeply by the unyielding cortical bone of P3, the subungual space behaves as a closed, rigid osteofibrous compartment. When a rapidly growing, squamoproliferative keratoacanthoma expands within this inextensible space, it cannot expand outward without causing marked onycholysis. Consequently, internal hydraulic and mechanical pressure is transmitted directly onto the underlying periosteum and dorsal cortical plate of the distal phalanx. This relentless localized pressure stimulates osteoclast-mediated bone resorption, creating the characteristic smooth, crescentic, cup-shaped cortical saucerization of P3 without true malignant trabecular infiltration.

Digital Neurovascular Danger Zones and Internervous Intervals

Surgical management of subungual and digital lesions requires rigorous adherence to neurovascular danger zones to prevent iatrogenic sensory impairment, vascular compromise, or digital necrosis:

• Proper Digital Neurovascular Bundles: The paired proper digital arteries and proper digital nerves course along the ventrolateral aspects of the digit. They are anatomically secured by Cleland’s ligament (passing dorsal to the bundle from the phalanges to the skin) and Grayson’s ligament (passing volar to the bundle). Surgical dissection around the distal interphalangeal (DIP) joint and lateral nail folds must respect these fascial planes to avoid direct nerve laceration or thermal injury from electrocautery.
• Dorsal Digital Arterial Arborization: Proximal to the DIP joint, the proper digital artery gives off an essential dorsal branch that traverses toward the midline to supply the germinal matrix and eponychium, before continuing as the digital pulp artery to form the terminal vascular arcade of the distal tuft. Excessive lateral or proximal dissection during eponychial elevation can sever this dorsal branch, leading to ischemia of the nail matrix or full-thickness necrosis of the proximal nail fold.
• Sensory Innervation and Danger Zones: Sensory innervation of the dorsal digital tip is derived from dorsal branches of the proper digital nerves, supplemented on the dorsum of the proximal and middle phalanges by the superficial branch of the radial nerve (digits 1 to 3 and radial half of digit 4) or the dorsal sensory branch of the ulnar nerve (digit 5 and ulnar half of digit 4). Aggressive dissection into the lateral perionychial sulcus risks transecting terminal digital nerve branches, resulting in painful neuroma formation or permanent numbness of the digital tip pulp.
• Surgical Intervals and Exposure Planes: Operative exposure of the distal phalanx and nail bed does not employ a traditional muscular internervous plane because no intrinsic muscle bellies exist distal to the metacarpophalangeal joints. Instead, surgical exposure relies on precise internervous and intervascular fascial intervals: bilateral paronychial relaxing incisions, partial or complete nail plate avulsion, or a midlateral digital incision placed strictly dorsal to the neurovascular bundle (dorsal to Cleland’s ligament) to access the lateral aspect of P3 safely.

3. Pathogenesis

The pathogenesis of keratoacanthoma reflects a complex interplay of environmental mutagenic insults, somatic oncogenic driver mutations, dysregulated intracellular signaling cascades, and distinct immunologic mechanisms that drive its unique triphasic evolutionary life cycle.

The Triphasic Evolutionary Cycle

Classic cutaneous keratoacanthoma exhibits a remarkable, self-limiting biological life cycle divided into three distinct phases:

• Proliferative Phase: Spanning 4 to 8 weeks, this phase is characterized by rapid, explosive epithelial proliferation. Squamoid cells originating from follicular or nail bed epithelium proliferate downward into the reticular dermis as large, bulbous, well-demarcated lobules. The proliferating keratinocytes exhibit abundant, pale, glassy eosinophilic cytoplasm resulting from extensive accumulation of tonofilaments and cytoplasmic glycogen. Mitotic figures are frequent in the peripheral basal layers but demonstrate normal bipolar morphology without atypical or bizarre mitotic forms.
• Mature Phase: Lasting 2 to 8 weeks, volumetric expansion ceases. The central keratinocytes undergo synchronized, accelerated terminal differentiation, forming concentric lamellated horn pearls and accumulating an extensive central mass of dense, compact orthokeratotic and parakeratotic keratin. This creates a massive, crateriform core surrounded by overlapping shoulders of normal epidermis, termed epidermal buttressing lips.
• Involuting Phase: Over 6 to 12 months, the lesion undergoes spontaneous immune-mediated regression. Dense host cell-mediated immune infiltration occurs along the deep base, driven by CD8+ cytotoxic T lymphocytes, CD4+ T helper cells, and natural killer cells. Upregulation of the Fas/Fas-ligand apoptotic pathway, granzyme B release, and perforin-mediated cytotoxicity trigger massive apoptosis of neoplastic keratinocytes. Concurrently, microvascular regression and thrombosis within the stromal stalks lead to ischemic necrosis of the central squamoid mass. The large keratin crater is extruded or sloughed, and the defect heals by secondary intention with extensive dermal fibrosis, resulting in an atrophic, depressed, cribriform scar.

Molecular Genetics and Mutational Profile

Ultraviolet (UVB) radiation serves as the primary environmental carcinogen. Mutational profiling reveals signature UV-induced C-to-T and CC-to-TT dipyrimidine transition mutations within the TP53 tumor suppressor gene, impairing p53-dependent cell cycle arrest and apoptosis. In addition, activating point mutations in the HRAS and KRAS proto-oncogenes (most commonly targeting codons 12 and 61) are identified in 20% to 30% of sporadic solitary keratoacanthomas, driving constitutive signaling through the downstream mitogen-activated protein kinase (MAPK) pathway.

Despite these shared driver mutations with invasive cutaneous squamous cell carcinoma, comparative genomic hybridization and next-generation sequencing reveal critical differences: keratoacanthomas harbor significantly fewer chromosomal copy number aberrations and structural chromosomal rearrangements. While invasive cSCC exhibits extensive genomic instability, aneuploidy, and frequent copy number gains at 3q, 5p, and 8q with losses at 3p, 9p, and 13q, keratoacanthoma displays a relatively stable diploid or near-diploid karyotype, explaining its intrinsic biological capacity for terminal differentiation and self-regression.

Paradoxical MAPK Activation and Drug-Induced Keratoacanthomas

A profound insight into the molecular biology of keratoacanthoma emerged with the clinical introduction of targeted BRAF inhibitors (such as vemurafenib and dabrafenib) for the treatment of BRAF V600E-mutant metastatic melanoma. Between 15% and 30% of patients receiving BRAF inhibitor monotherapy develop solitary or eruptive keratoacanthomas and well-differentiated cSCC within 2 to 12 weeks of initiating therapy.

This phenomenon is mediated by paradoxical MAPK pathway activation. In normal or premalignant keratinocytes that harbor wild-type BRAF and preexisting, subclinical UV-induced RAS mutations, the ATP-competitive BRAF inhibitor binds to wild-type BRAF monomers. This binding promotes the formation of BRAF-CRAF heterodimers and CRAF homodimers. Rather than inhibiting signaling, this drug-bound dimer structure induces allosteric transactivation of the drug-free partner kinase, drastically hyperactivating downstream MEK and ERK phosphorylation. This hyper-activation drives uncontrolled squamoproliferative expansion of latent keratinocytes into fully formed keratoacanthomas. Co-administration of a MEK inhibitor (such as trametinib or cobimetinib) successfully blocks this downstream signaling cascade, reducing the incidence of BRAF-inhibitor-induced keratoacanthomas to less than 2%.

Syndromic Pathogenesis and Hereditary Instability

Specific genetic syndromes provide critical evidence regarding inherited squamoproliferative susceptibility:

• Muir-Torre Syndrome: An autosomal dominant phenotypic variant of Lynch syndrome (hereditary non-polyposis colorectal cancer). Muir-Torre syndrome is driven by germline loss-of-function mutations in DNA mismatch repair genes, predominantly MSH2 (accounting for approximately 90% of cases), followed by MLH1, MSH6, and PMS2. Inactivation of the second allele leads to profound microsatellite instability (MSI-High), accelerating the accumulation of frameshift mutations across coding microsatellite regions. Patients develop multiple sebaceous neoplasms alongside solitary or eruptive keratoacanthomas, accompanied by internal visceral malignancies (colorectal, endometrial, urological, and small bowel adenocarcinomas).
• Multiple Familial Keratoacanthoma (Ferguson-Smith Type): An autosomal dominant disorder mapped to chromosome 9q22.3, caused by germline loss-of-function mutations in the TGFBR1 gene, which encodes transforming growth factor-beta receptor type 1. Disruption of the TGF-beta signaling axis abrogates its critical tumor-suppressive and antiproliferative regulatory control over epidermal keratinocytes, leading to recurrent crops of locally invasive keratoacanthomas that develop during adolescence or early adulthood, undergo spontaneous involution, and leave disfiguring cribriform scars.
• Generalized Eruptive Keratoacanthomas of Grzybowski: A rare, sporadic squamoproliferative syndrome occurring in late adult life, characterized by the sudden onset of hundreds to thousands of diffuse, tiny follicular papules involving the skin and mucous membranes. Its pathogenesis is linked to profound systemic immune dysregulation, paraproteinemias, or pharmacological immunosuppression following solid-organ transplantation.

4. Natural History

Understanding the natural history of keratoacanthoma is paramount for surgical decision-making, particularly when distinguishing between common cutaneous lesions and destructive subungual presentations.

Epidemiology and Demographic Risk Factors

Keratoacanthoma predominantly affects elderly, light-skinned individuals, with peak incidence occurring in the 6th through 8th decades of life (mean age of presentation approximately 65 to 68 years). The overall male-to-female ratio is estimated at 2:1. Epidemiological distribution closely parallels that of cutaneous squamous cell carcinoma:

• Sun-Exposed Cutaneous Predilection: More than 75% to 80% of solitary cutaneous keratoacanthomas arise on chronically sun-exposed anatomical sites, with the dorsal hands, extensor forearms, face (cheeks, nose, lower lip), neck, and scalp representing the vast majority of cases.
• Phenotypic and Environmental Risk Factors: High susceptibility is strongly linked to Fitzpatrick skin phototypes I and II, excessive cumulative outdoor ultraviolet radiation exposure, exposure to industrial chemical carcinogens (coal tar, pitch, polycyclic aromatic hydrocarbons, mineral oils), cigarette smoking, previous therapeutic ionizing radiation, and human papillomavirus infection (subtypes 9, 11, 13, 16, 25).
• Iatrogenic Immunosuppression: Patients maintained on chronic immunosuppressive regimens following solid-organ transplantation (such as kidney, heart, or liver recipients on calcineurin inhibitors, azathioprine, or mycophenolate mofetil) exhibit an estimated 30- to 65-fold increased incidence of keratoacanthomas and cSCC, often presenting with multiple, aggressive, or recurrent lesions.

Temporal Dynamics and Involution of Classic Cutaneous Lesions

The natural progression of solitary cutaneous keratoacanthoma is defined by its explosive growth velocity, which frequently causes intense clinical alarm. Within 4 to 8 weeks, a subtle, asymptomatic pink macule or papule rapidly expands into a discrete, firm, dome-shaped nodule measuring 1 to 2.5 cm in diameter, dominated by a prominent central keratotic core.

Following this explosive proliferative phase, the lesion stabilizes during a stationary phase of 2 to 8 weeks. Subsequently, spontaneous immune-mediated involution begins, progressing over a period of 6 to 12 months (median duration approximately 6 months). As keratinocyte apoptosis and stromal microvascular regression proceed, the central keratin crater is sloughed. The resulting wound heals by contracture and re-epithelialization, consistently leaving an irregular, depressed, hypopigmented, atrophic cribriform scar. When involution occurs in anatomically sensitive areas, such as the lower eyelid, alar rim of the nose, or vermilion border of the lip, this severe cicatrix causes permanent cosmetic deformity, ectropion, or functional impairment.

The Subungual Keratoacanthoma Exception

Subungual keratoacanthoma represents a critical biological exception to the paradigm of spontaneous regression. Confined within the non-compliant, rigid osteofibrous space between the nail plate, lateral perionychial folds, and the dorsal cortex of the distal phalanx (P3), SKA exhibits a relentless, non-involuting clinical course.

Documented cases of complete spontaneous regression in subungual keratoacanthoma are exceedingly rare (less than 2%). Unlike cutaneous lesions, which expand outward into the yielding surrounding skin, the subungual tumor is constrained by the overlying rigid keratin nail plate. As the mass proliferates, it exerts progressive hydrostatic and mechanical pressure directly inward against the distal phalanx. This uninterrupted pressure stimulates localized osteoclastic activation, leading to progressive cortical osteolysis and extensive bone resorption.

Left untreated, subungual keratoacanthoma does not resolve; rather, it results in complete destruction of the nail bed, pathological fracture or massive erosion of the distal phalanx, intractable throbbing digital pain, and frequent secondary bacterial superinfection (acute paronychia, felon, or chronic osteomyelitis). Consequently, expectant management or “watchful waiting” is strictly contraindicated in subungual keratoacanthoma, and prompt definitive operative intervention is mandatory.

5. Clinical Presentation

A rigorous clinical evaluation combines a targeted history with precise anatomical and provocative physical examination maneuvers to differentiate keratoacanthoma from aggressive malignant counterparts and benign mimics.

History

The patient history provides vital diagnostic clues that immediately narrow the differential diagnosis:

• Symptom Chronology and Growth Kinetics: In solitary cutaneous lesions, patients describe a startlingly rapid onset, with an explosive mass developing over a timeframe of 3 to 6 weeks. Indolent, slow-growing lesions progressing over many months or years are far more characteristic of conventional cutaneous squamous cell carcinoma, basal cell carcinoma, or verruca vulgaris.
• Digital Pain Characteristics in Subungual Lesions: Patients presenting with subungual KA report intense, deep, throbbing, pulsatile pain localized to the distal digit. This pain is disproportionately severe compared to cutaneous KA, exacerbated by dependent hand positioning or minor mechanical contact, and frequently disrupts sleep due to elevated intra-compartmental pressure beneath the unyielding nail plate.
• History of Misdiagnosis and Ineffective Treatments: In subungual presentations, patients almost universally recount multiple failed courses of oral and topical antibiotics, antifungal lacquers, or repeated needle aspirations and minor drainage procedures by primary clinicians operating under the mistaken impression of an intractable bacterial paronychia, felon, onychomycosis, verruca vulgaris, or pyogenic granuloma.
• Antecedent Mechanical Trauma: Up to 30% of patients with subungual KA report an inciting mechanical injury, crush trauma, foreign body penetration (such as a wood or metal splinter), or previous minor digital surgery 1 to 3 months prior to the onset of the lesion.
• Pharmacologic and Oncologic Review: Specific inquiry must be made regarding recent treatment with targeted oncologic agents, particularly selective BRAF inhibitors (vemurafenib, dabrafenib), immune checkpoint inhibitors, or systemic post-transplant immunosuppression.
• Family and Personal Cancer History: A personal or family history of early-onset colorectal cancer, endometrial adenocarcinoma, or multiple recurring sebaceous skin tumors should immediately raise clinical suspicion for underlying Muir-Torre syndrome.

Physical Exam

Physical examination encompasses both gross morphological inspection of the lesion and specialized hand examination maneuvers:

• Cutaneous Lesion Morphology: Classic cutaneous KA appears as a symmetric, dome-shaped, firm, flesh-colored to erythrodermic or violaceous nodule with smooth, shiny, telangiectatic peripheral borders. The hallmark feature is a central, crateriform crater packed with an adherent, hyperkeratotic, brown-to-yellow orthokeratotic and parakeratotic keratin plug. The surrounding normal epidermis stretches and rolls over the lateral margins of the crater, forming an overhanging epidermal collar (buttressing lips).
• Subungual Inspection and Perionychial Architecture: Inspection of the affected digit reveals distal and lateral onycholysis (progressive detachment of the nail plate from the underlying sterile bed). A hyperkeratotic, verrucous, firm, pink-to-yellow subungual mass is frequently seen protruding beneath the free margin of the hyponychium. The nail plate is often displaced dorsally, exhibiting longitudinal cracking, discoloration, or severe dystrophic deformation. Erythema and edematous swelling of the lateral and proximal nail folds are common, closely mimicking acute paronychia.
• Digital Pulp and Joint Palpation: Palpation reveals a firm, non-fluctuant, exquisitely tender subungual mass. The active and passive range of motion of the distal interphalangeal (DIP) joint must be documented; DIP joint motion is characteristically preserved and painless in subungual KA, effectively ruling out primary septic arthritis or acute DIP flexor tenosynovitis.
• Love’s Pin Test: Evaluated by applying gentle, focal pressure across the nail plate with the tip of a sterile paperclip or pin. In glomus tumors, this test elicits agonizing, pinpoint focal tenderness localized to a single 1-mm zone (Sensitivity 100%, Specificity 78%). In keratoacanthoma, tenderness is diffuse across the entire subungual mass rather than exquisitely pinpoint, assisting in clinical differentiation.
• Hildreth Cold Sensitivity Test: Cold sensitivity is tested by exposing the digit to an ice cube or cold-water bath, followed by repeating the test under digital tourniquet ischemia. In glomus tumors, cold exposure provokes severe, paroxysmal pain that is dramatically relieved by tourniquet inflation (Sensitivity 92%, Specificity 91%). In subungual keratoacanthoma, the Hildreth test is negative; cold exposure does not precipitate paroxysmal pain cascades.
• Transillumination Test: A high-intensity fiberoptic light source is placed directly against the digital pulp. Subungual keratoacanthoma appears as an opaque, dark, non-transilluminating dense mass. In contrast, digital mucous cysts, epidermoid inclusion cysts, and simple seromas readily transilluminate.
• Regional Lymph Node Examination: Meticulous bilateral palpation of the epitrochlear, axillary, cervical, and supraclavicular lymph node basins is mandatory. In classic keratoacanthoma, regional lymphadenopathy is absent or represents mild, soft, mobile, reactive inflammatory enlargement. The presence of hard, fixed, non-tender, or matted lymph nodes strongly indicates metastatic invasive cutaneous squamous cell carcinoma or amelanotic melanoma, demanding immediate staging workup.

6. Imaging and Diagnostic Studies

The diagnostic evaluation of keratoacanthoma adheres to a strict hierarchy, transitioning from plain radiographs in digital lesions to dermoscopy, advanced cross-sectional imaging, and definitive histopathological biopsy.

Plain Radiography

Plain radiography represents the mandatory initial diagnostic imaging modality for all suspected subungual or digital lesions:

• Standard Radiographic Projections: High-resolution posteroanterior (PA), dedicated lateral, and oblique views of the affected digit, obtained with dedicated fine-detail soft tissue and osseous parameters.
• Classic Crescentic Cortical Saucerization: The pathognomonic radiographic sign of subungual keratoacanthoma is a smooth, well-circumscribed, crescentic, cup-shaped cortical saucerization (pressure erosion defect) along the dorsal or terminal aspect of the distal phalanx (P3).
• Preserved Cortical Architecture and Narrow Zone of Transition: The base of the osteolytic bone defect is demarcated by a thin, smooth, intact sclerotic rim. The zone of transition between the eroded bone and adjacent normal bone is exceedingly narrow. There is a complete absence of true trabecular permeation, moth-eaten bone destruction, or internal matrix mineralization (such as osteoid or chondroid rings and arcs).
• Absence of Malignant Periosteal Reaction: The periosteal margins remain non-reactive, with zero evidence of Codman’s triangles, sunburst spiculation, or laminated periostitis. This distinctive lack of permeative destruction and periosteal reaction reliably distinguishes subungual KA from primary bone malignancies (such as osteosarcoma, chondrosarcoma, or Ewing sarcoma), metastatic carcinoma to the distal phalanx, and advanced invasive squamous cell carcinoma with direct bone invasion.

Advanced Imaging: Magnetic Resonance Imaging and Ultrasound

While plain radiographs are definitive for bony assessment, advanced imaging modalities provide critical soft-tissue anatomical resolution:

• Magnetic Resonance Imaging (MRI): Indicated when a subungual lesion extends proximally beneath the germinal matrix toward the DIP joint, when plain radiographs demonstrate ambiguous bone changes, or to confirm soft-tissue margins prior to surgery. On T1-weighted sequences, a well-circumscribed, homogeneous hypointense to isointense mass depresses the dorsal cortex of the distal phalanx. On T2-weighted and STIR sequences, an intermediate to hyperintense heterogeneous mass is noted with central hypointense foci (compact keratin debris) and a thin hypointense rim (fibrous pseudocapsule). Post-contrast fat-suppressed T1 sequences demonstrate robust peripheral and stromal enhancement surrounding a non-enhancing central necrotic core, confirming a smooth pushing border against unbreached periosteum without medullary infiltration or marrow edema.
• High-Resolution Diagnostic Ultrasound (15 to 22 MHz): Demonstrates a well-demarcated, inhomogeneous, predominantly hypoechoic subungual mass with an anechoic central crater. Color Doppler interrogation reveals prominent peripheral and stromal microvascularity without arteriovenous shunting, differentiating KA from highly vascular glomus tumors (which exhibit intense, uniform intratumoral arterial flow).

Dermoscopy

Dermoscopic evaluation provides rapid non-invasive bedside assessment:

• Central Keratin Core: A central, structureless, amorphous yellowish-white or orange-brown keratinaceous mass corresponding to the central crater.
• Targetoid White Circles and Halos: Concentric, discrete white circles or halos surrounding follicular openings or keratin pearls, representing acanthotic squamous cuffs.
• Peripheral Polymorphous Vascular Architecture: A characteristic radial vascular arrangement at the periphery of the keratin crater, featuring elongated hairpin vessels surrounded by white halos, linear-irregular vessels, and occasional glomerular vessels. Dermoscopy lacks the irregular pigment networks, blue-white veils, or atypical polymorphic vessels seen in malignant melanoma and poorly differentiated cSCC.

Biopsy Technique and Histopathological Benchmarks

Histopathological evaluation represents the definitive gold standard for diagnosis, but diagnostic accuracy is entirely contingent upon proper biopsy technique:

• The Strict Prohibition on Superficial Biopsy: Superficial shave biopsies, surface scrapings, curettage samples, and shallow punch biopsies (< 3 mm depth) are strictly contraindicated when keratoacanthoma is suspected. These inadequate techniques sample only the superficial keratinaceous plug or superficial cytologic atypia, leading to two catastrophic diagnostic errors: underdiagnosis as a benign verruca or hyperkeratosis, or false-positive overdiagnosis of deeply invasive squamous cell carcinoma, which has historically prompted unnecessary digital amputations.
• Mandatory Full-Thickness Biopsy Architecture: For lesions smaller than 1.5 cm, complete primary excisional biopsy is preferred. For larger lesions, a deep, full-thickness fusiform or wedge incisional biopsy must be performed traversing the entire center of the lesion down into the subcutaneous fat or periosteal base. An adequate biopsy must capture three mandatory architectural landmarks: both lateral epidermal buttressing lips showing normal adjacent epidermis rolling over the crater, the full vertical crater core containing compact orthokeratotic and parakeratotic keratin, and the deep advancing frontier (base) composed of broad, smooth, rounded, pushing bulbous lobules of well-differentiated squamous epithelium with abundant pale, glassy eosinophilic cytoplasm, minimal nuclear pleomorphism, and a complete absence of single-cell stromal infiltration, desmoplasia, or perineural invasion.

7. Classification

Keratoacanthomas are classified according to clinical morphology, anatomic distribution, solitary versus eruptive presentation, and underlying syndromic or genetic associations. This classification directly governs clinical workup and operative management:

8. Treatment

The management of keratoacanthoma requires an evidence-based algorithm tailored to the anatomical location, growth velocity, histological certainty, and syndromic profile of the patient.

Medical / Nonoperative

Nonoperative medical modalities are reserved for selected patients with solitary cutaneous lesions where surgical intervention is precluded by extreme medical comorbidity, lesions located in cosmetically delicate facial zones where wide resection would cause severe aesthetic morbidity, or patients with diffuse eruptive syndromic variants:

• Intralesional 5-Fluorouracil (5-FU): The most widely validated non-surgical therapy for cutaneous keratoacanthoma. Formulated at a concentration of 50 mg/mL, a volume of 0.2 to 2.0 mL is injected directly into the deep base and peripheral margins of the lesion using a 30-gauge needle. Injections are administered weekly or bi-weekly for 2 to 6 cycles. 5-FU functions as a pyrimidine analog that irreversibly inhibits thymidylate synthase, halting DNA synthesis and driving massive apoptotic cell death in rapidly proliferating keratinocytes. Clinical series demonstrate complete tumor clearance rates of 85% to 95%.
• Intralesional Methotrexate: Administered at a concentration of 12.5 to 25 mg/mL (1 to 2 mL per session, given every 2 to 3 weeks for 2 to 4 sessions). Highly effective in inducing complete regression, particularly in large cutaneous lesions, with lower rates of localized ulceration and tissue necrosis compared to high-dose 5-FU.
• Systemic Retinoids (Oral Acitretin and Isotretinoin): The definitive first-line medical therapy for generalized eruptive keratoacanthomas (Grzybowski type) and multiple familial keratoacanthomas (Ferguson-Smith type). Acitretin is initiated at 0.5 to 1.0 mg/kg/day, binding to nuclear retinoic acid receptors to suppress squamoproliferative transcription and accelerate terminal keratinocyte cornification. Retinoids significantly decrease tumor eruptive frequency and accelerate regression.
• Topical Immunomodulators and Chemotherapy: Topical 5% imiquimod cream (a Toll-like receptor 7 agonist stimulating local interferon-alpha and cell-mediated immunity) or topical 5% 5-FU cream applied twice daily under occlusion for 6 to 12 weeks. These serve as adjunctive therapies for superficial lesions or residual margin dysplasias.
• Objective Failure Criteria: Strict clinical failure criteria must be enforced. If a lesion fails to demonstrate at least a 30% reduction in volume within 3 to 4 weeks of medical therapy, or if any interval tumor enlargement or ulceration occurs, medical therapy must be immediately terminated and prompt surgical excision executed.
• Absolute Medical Contraindication: Nonoperative observation or primary medical/topical therapy is strictly contraindicated in subungual keratoacanthoma. Because subungual lesions do not reliably regress and cause rapid, irreversible pressure osteolysis of the distal phalanx, primary surgical intervention is mandatory.

Operative

Surgical intervention represents the definitive standard of care for keratoacanthoma. The fundamental goals of surgery are:

• Complete oncologic eradication of the squamoproliferative mass with histologically confirmed negative surgical margins.
• Procurement of an intact, full-thickness surgical specimen to definitively rule out invasive cutaneous squamous cell carcinoma.
• Maximal functional preservation of adjacent musculoskeletal structures, joint motion, and digital pulp sensation.
• Preservation of the distal phalanx and total avoidance of unnecessary digital amputation in subungual presentations.

Primary operative modalities include:

• Complete Surgical Excision with 4 to 5 mm Margins: Standard of care for solitary cutaneous lesions located on the extremities, trunk, or non-critical zones. An elliptical incision is designed with 4 to 5 mm peripheral margins of normal skin, oriented along relaxed skin tension lines. Dissection extends through the full dermis into the superficial subcutaneous adipose layer to ensure complete clearance of the deep pushing frontier. The wound is closed primarily in layers, or reconstructed with local advancement flaps or full-thickness skin grafts if primary closure induces excessive tissue tension.
• Mohs Micrographic Surgery (MMS): The gold standard surgical modality for lesions located in cosmetically and functionally critical anatomical regions (the digits, hands, face, nose, eyelids, lips, ears), recurrent lesions, or lesions larger than 2 cm in diameter. Mohs surgery provides 100% intraoperative peripheral and deep surgical margin evaluation via frozen section processing while sparing the maximum amount of uninvolved healthy digital and cutaneous tissue, achieving cure rates exceeding 98%.
• Conservative Curettage and Saucerization for Subungual KA: The definitive limb-salvage surgical procedure for subungual keratoacanthoma. A digital block is performed strictly without epinephrine and a digital tourniquet is applied for hemostasis. The nail plate is avulsed using a Freer elevator to expose the tumor bed. Circumferential full-thickness incisional margins are created, the keratinaceous core is debulked sharply, and open sharp ring curettes are utilized to aggressively curette the tissue down to the firm cortical floor of the distal phalanx crater. Chemical cauterization with 80% trichloroacetic acid or light electrodessication is applied to the bony bed, while meticulously preserving the germinal matrix and digital neurovascular bundles. The cleansed, fenestrated native nail plate is reinserted beneath the eponychium and secured with horizontal mattress sutures as a biological stent.

Indications and Contraindications

Indications for Operative Intervention:

• Any subungual squamoproliferative mass demonstrating onycholysis, progressive digital pain, or plain radiographic distal phalanx cortical saucerization.
• Any rapidly growing cutaneous squamoproliferative nodule where histopathological differentiation between keratoacanthoma and invasive cSCC cannot be definitively established on clinical or biopsy evaluation.
• Lesions larger than 10 mm in diameter, or those located in functionally critical anatomical zones (digits, hands, periorbital, perioral).
• Lesions demonstrating clinical failure or progression following nonoperative medical trials.

Absolute Contraindications:

• Primary Digital Amputation (Trans-DIP or Ray Amputation): Strictly contraindicated as an initial or primary procedure for subungual keratoacanthoma. Digital amputation is reserved exclusively for rare, confirmed cases of high-grade, medullary-infiltrating invasive cSCC with true cortical breakthrough, or severe secondary osteomyelitis with irreparable destruction of the DIP joint.
• Blind Destructive Modalities: Liquid nitrogen cryosurgery, blind curettage without histological submission, or laser ablation are strictly contraindicated because they destroy the diagnostic tissue architecture required to rule out invasive malignancy.

9. Outcome

Clinical and functional outcomes following the treatment of keratoacanthoma are exceptionally favorable when definitive surgical guidelines are observed, with high rates of local disease control and complete digital preservation.

Local Oncologic Control and Recurrence Rates

Complete surgical excision of solitary cutaneous keratoacanthoma with 4 to 5 mm margins achieves cure rates between 92% and 98%, with overall local recurrence rates reported between 2% and 8%. In functionally sensitive regions (such as the digits and face), Mohs micrographic surgery achieves cure rates exceeding 98%, with local recurrence rates below 2%.

In subungual keratoacanthoma, conservative local excision combined with thorough curettage and chemical or thermal ablation yields local control rates between 90% and 95%. When local recurrences do arise, they typically occur within 2 to 6 months postoperatively and can be successfully managed with repeat conservative curettage, avoiding escalation to digital amputation in over 95% of recurrent cases.

Distal Phalanx Bone Remodeling and Osseous Reconstitution

A remarkable clinical outcome in subungual keratoacanthoma is the biological capacity of the distal phalanx to undergo complete spontaneous osseous remodeling following tumor eradication. Because the smooth cortical saucerization is an osteoclast-mediated response to hydrostatic compartment pressure rather than true neoplastic cellular infiltration of bone trabeculae, removal of the expansile tumor mass relieves this mechanical stimulus.

Serial plain radiographs obtained at 3, 6, and 12 months postoperatively consistently demonstrate active osteoblastic bone deposition, with complete reconstitution of the dorsal cortical plate and remineralization of the distal phalanx crater occurring within 9 to 12 months in more than 85% of patients. This radiographic normalization eliminates any clinical justification for radical digital amputation.

Functional Recovery and Patient-Reported Outcome Measures

Functional preservation following conservative, digit-sparing curettage for subungual KA is outstanding:

• Validated Hand Function Metrics: Validated patient-reported outcome measures, including the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) score and Michigan Hand Outcomes Questionnaire (MHQ), demonstrate return to baseline upper extremity function, with mean QuickDASH scores under 12 points and MHQ scores exceeding 88 out of 100.
• Range of Motion and Digital Strength: The active flexion-extension arc of the distal interphalangeal joint is fully preserved in over 95% of patients. Key pinch strength, tip pinch, and grip strength return to 90% to 100% of the contralateral uninjured extremity. In stark contrast, primary trans-DIP digital amputation results in permanent loss of DIP motion, decreased pinch stability, and significant functional impairment.
• Nail Plate Regrowth and Cosmesis: When the germinal matrix is meticulously preserved during curettage and stented with the native nail plate, cosmetically acceptable, functional nail regrowth occurs in 75% to 85% of patients. Residual minor onychodystrophy (such as mild longitudinal ridging, split nail, or distal onycholysis) occurs in approximately 15% to 20% of cases, but rarely causes functional disability.

10. Complications

Complications associated with keratoacanthoma management are categorized chronologically into immediate intraoperative events, early postoperative occurrences, and late long-term sequelae:

11. Pearls and Pitfalls

Synthesized operative pearls and clinical pitfalls distinguish master surgical decision-making and prevent catastrophic iatrogenic errors:

• The Full-Thickness Wedge Biopsy Rule: Never perform a superficial shave, scrape, or shallow punch biopsy when keratoacanthoma is in the differential diagnosis. A superficial sample inevitably catches only the central keratin plug or superficial dyskeratosis, generating false-positive reports of invasive cSCC or misleading reports of benign verruca. Always obtain a deep, full-thickness incisional wedge biopsy traversing normal skin, the overhanging epidermal buttressing lip, the keratin core, and the deep pushing base.
• Distinguishing Cortical Saucerization from True Infiltration: In subungual presentations, smooth crescentic cortical bone saucerization on plain radiographs is a physical manifestation of external hydraulic pressure remodeling, not malignant bone invasion. Do not interpret this osseous depression as an indication for radical digital amputation; thorough conservative curettage preserves the digit, and the bone will reliably re-ossify.
• The Repositioned Native Nail Plate as a Biological Stent: Following tumor curettage and bed cauterization, never discard the avulsed nail plate. Cleanse it in povidone-iodine, drill 4 to 6 fenestrations with an 18-gauge needle for continuous exudate drainage, and slide it back beneath the eponychial fold. Secure it with 4-0 chromic horizontal mattress sutures. This acts as the perfect physiological stent, preventing cicatricial synechia between the eponychium and germinal matrix and guiding smooth, non-dystrophic nail bed re-epithelialization.
• BRAF-Inhibitor Pharmacovigilance: When an oncology patient receiving vemurafenib or dabrafenib develops eruptive squamoproliferative lesions, do not prematurely discontinue life-saving melanoma therapy. These drug-induced keratoacanthomas arise from paradoxical MAPK activation in pre-existing RAS-mutant keratinocytes; manage solitary lesions with conservative local excision, or recommend the addition of a MEK inhibitor (trametinib) to suppress paradoxical downstream signaling.
• The Refractory Paronychia Trap: Beware the patient presenting with presumed chronic bacterial paronychia or felon that has failed multiple rounds of oral antibiotics and superficial incisions. In any adult with rapid digital tip swelling, severe throbbing pain, onycholysis, and normal inflammatory markers, obtain three-view plain radiographs immediately to look for distal phalanx cortical saucerization.
• The Watchful Waiting Disaster in Digits: While solitary cutaneous keratoacanthoma can technically undergo spontaneous regression, never adopt a watchful waiting approach for subungual keratoacanthoma. Confined within the rigid subungual osteofibrous box, subungual lesions do not reliably involute and will cause progressive cortical osteolysis, severe intractable pain, and permanent nail bed destruction. Prompt surgical intervention is mandatory.

12. Controversy

Several profound controversies persist regarding the biological classification, diagnostic evaluation, and operative management of keratoacanthoma:

• Benign Pseudomalignancy versus Well-Differentiated Cutaneous Squamous Cell Carcinoma Variant: The most enduring debate in dermatopathology and surgical oncology centers on whether keratoacanthoma represents an entirely distinct, benign, self-involuting pseudomalignancy or merely an abortive, well-differentiated variant of cutaneous squamous cell carcinoma (termed cSCC with keratoacanthoma-like features). Proponents of the distinct entity hypothesis cite its stereotyped triphasic life cycle, programmed spontaneous regression, near-diploid karyotype, and low rates of chromosomal copy number variation. Conversely, proponents of the cSCC continuum emphasize that keratoacanthomas harbor overlapping UV-signature TP53, HRAS, and NOTCH1/2 mutations, can exhibit perineural and intravascular invasion in up to 2% to 4% of cases, and possess rare documented instances of regional lymph node metastasis. Due to the impossibility of guaranteeing clinical involution in any individual patient, modern clinical consensus mandates managing keratoacanthomas with the same oncologic rigor and clear-margin surgical excision as well-differentiated cSCC.
• Diagnostic Reliability of Frozen Section Analysis and Partial Biopsy: A major operative controversy concerns the safety of relying on intraoperative frozen sections to dictate the extent of resection or digit amputation. Dermatopathology multi-center studies report diagnostic discordance rates of 20% to 35% between intraoperative frozen sections and permanent paraffin-embedded sections. Incomplete specimens lack the architectural overview of the symmetrical epidermal buttressing lips and smooth pushing base, frequently leading to overdiagnosis of invasive cSCC. Consequently, hand surgery consensus strongly discourages performing digital amputations based solely on frozen section diagnoses, mandating permanent paraffin section evaluation and multidisciplinary clinicopathological consensus before executing non-salvageable digital resections.
• Active Surgical Intervention versus Expectant Observation in Cutaneous Lesions: A subset of clinicians argues that given the established natural history of spontaneous involution, solitary cutaneous keratoacanthomas in non-critical sites could theoretically be managed expectantly with serial photographic monitoring. However, the overwhelming orthopaedic and dermatologic surgical consensus strongly rejects expectant management. Spontaneous involution is unpredictable in onset and duration, leaving an unsightly, depressed, cribriform scar that is aesthetically inferior to a planned, primary surgical closure scar. Furthermore, delaying intervention risks allowing an misdiagnosed, aggressive, invasive cSCC to progress to advanced local invasion or regional nodal metastasis.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Kwiek B, Schwartz RA. Keratoacanthoma (KA): An update and review. J Am Acad Dermatol. 2016. doi:10.1016/j.jaad.2015.11.033 [Level IV: Systematic Review / Consensus Cohort Analysis]
• Schwartz RA. Keratoacanthoma. J Am Acad Dermatol. 1994. doi:10.1016/s0190-9622(94)70001-x [Level IV: Landmark Clinical Review / Multi-cohort Study]
• Patel MR, Desai S. Subungual keratoacanthoma in the hand. J Hand Surg Am. 1989. doi:10.1016/0363-5023(89)90074-9 [Level IV: Clinical Case Series / Retrospective Cohort]
• Miguel-Gomez L, Turrion-Merino L, Reguero-Calleja ME et al. Subungual Keratoacanthoma. Indian J Dermatol. 2015. doi:10.4103/0019-5154.169148 [Level IV: Clinical Case Series / Cohort Analysis]
• Larson PO. Keratoacanthomas treated with Mohs’ micrographic surgery (chemosurgery). A review of forty-three cases. J Am Acad Dermatol. 1987. doi:10.1016/s0190-9622(87)70134-0 [Level IV: Prospective/Retrospective Interventional Cohort]

15. Master Class Pro-Tip

Digit-Sparing Principles in Subungual Keratoacanthoma: Encountering a rapidly expanding, destructive subungual mass that has eroded a deep crescentic crater into the distal phalanx on plain radiographs triggers an immediate reflex to suspect aggressive, invasive squamous cell carcinoma or osteosarcoma, frequently prompting premature discussions of digital amputation. Never amputate a digit based on clinical appearance, plain radiographs, or a frozen section alone. The radiographic hallmark of subungual keratoacanthoma is a smooth, well-defined, cup-shaped cortical saucerization without trabecular permeation or periosteal reaction. Perform complete nail plate avulsion under digital block and tourniquet hemostasis, sharply excise the keratinaceous core, and aggressively curette the tumor base down to the firm cortical floor of the distal phalanx crater. Apply 80% trichloroacetic acid or light electrodessication to the bone base while strictly protecting the germinal matrix proximally and the digital neurovascular bundles laterally. Fenestrate the cleansed native nail plate and suture it back beneath the eponychium as a biological stent. Serial radiographs at 6 and 12 months will demonstrate complete osteoblastic re-ossification and cortical reconstitution of the distal phalanx, preserving full digit length, DIP motion, and sensation while delivering durable oncologic cure.

Master Class Surgical Pearl: Digit-Sparing Management in Subungual Keratoacanthoma